Recent studies on cardiac ␤-AR subtype stimulation have raised doubts as to whether the above signaling scheme pertains equally to both ␤ 1 -and ␤ 2 -ARs. Although it is known that ␤ 2 -AR is coupled to adenylyl cyclase more efficiently than ␤ 1 -AR, 7, 8 the functional relevance of ␤ 2 -AR signaling to modulate contractility or heart rate (HR) has been questioned because of a relatively smaller number of ␤ 2 -than ␤ 1 -ARs. 3, 4 In addition, in vitro studies have revealed a substantial diversity among species with respect to the magnitude of the ␤ 2 -AR effects and more importantly, with respect to the role of cAMP/PKA signaling. 4,9 -13 More recent studies in rat myocytes have shown that the ␤ 2 -AR-mediated inotropic effect is due to augmentation of I Ca by a local cAMP/PKA-dependent mechanism, because it is blocked by PKA inhibition. 14, 15 However, it is not clear whether the ␤ 2 -AR-induced local cAMP signaling in rat myocytes can be generalized to other mammals. In particular, it has been argued that the ␤ 2 -AR-induced positive inotropic effect in canine heart may be cAMP-independent, because cAMP production is not increased during ␤ 2 -AR stimulation. 13 Therefore, we compared cardiac chronotropic, inotropic, and lusitropic responses to ␤ 2 -AR versus ␤ 1 -AR stimulation in intact dogs and in ventricular myocytes. We systematically characterized the phosphorylation status of major cytoplasmic regulatory proteins (PLB, TnI, C protein, and glycogen phosphorylase) as well as cAMP levels or PKA activation after ␤-AR subtype stimulation to determine whether ␤ 2 -AR signaling is global or is restrained to certain domains. Furthermore, in isolated canine ventricular myocytes we determined whether cAMP/PKA signaling is essential for cardiac ␤ 2 -AR-mediated I Ca and contractile responses using PKA inhibitors.
Methods Materials
Norepinephrine (NE), reserpine, and H-89 were purchased from Sigma Chemical Co and Rp-cAMPS from Biolog Life Science Institute. Zinterol (Zin) was kindly supplied by Bristol-Myers Inc, ICI 118,551 (ICI) by Imperial Chemical Inc, CGP 20712A (CGP) by Ciba-Geigy, and bisoprolol (Bis) by Merck.
Measurements of ␤-AR Subtype Effects on HR, Left Ventricular Contractility, and Relaxation in the Intact Dog
␤-AR subtype stimulation was studied in adult anesthetized (pentothal), open-chest beagle dogs. Forty-eight hours before the experiments, the dogs were reserpinized (1.5 mg/kg body wt) to reduce the influence of endogenous catecholamines. NE (5 g/kg body wt) and Zin (50 g/kg body wt) were injected as a bolus into the left ventricle. The ␤ 1 -AR antagonist Bis (0.6 mg/kg body wt) was administered intravenously 10 minutes before Zin to block reflex ␤ 1 -AR stimulation and possible background catecholamine influence. This dose of Bis completely blocked the response to NE. The ␤ 2 -AR antagonist ICI (0.2 mg/kg body wt) was used 5 minutes before Zin in the presence of Bis. NE and Zin doses were chosen because preliminary experiments showed that they elicited a maximum inotropic response. HR, left ventricular pressure (LVP), and dP/dt were continuously recorded before and after drug administration. The half-time of relaxation (t 1/2 ) was derived from fast-speed recordings of LVP. At 30 seconds after the drug injection, free-wall left ventricular tissue was freeze-clamped.
Electrophysiological and Contractile Measurements in Isolated Cardiomyocytes
Left ventricular myocytes were isolated from hearts of beagle dogs with a standard enzymatic technique. 16 The cells were suspended in HEPES buffer (pH 7.4) containing (mmol/L) HEPES 20, CaCl 2 1, NaCl 137, KCl 5, dextrose 15, MgSO 4 1.3, and NaH 2 PO 4 1.2. Cell length was monitored from the bright-field image by an optical edge-tracking method using a photodiode array (model 1024 SAQ, Reticon) with a 3-ms time resolution. 16 I Ca was measured via the whole-cell patch-clamp technique using an Axopatch 1D amplifier (Axon Instruments Inc). 1 Cells were voltage-clamped at Ϫ40 mV to inactivate Na ϩ and T-type Ca 2ϩ channels. K ϩ currents were inhibited by 4 mmol/L 4-aminopyridine and 5.4 mmol/L CsCl instead of KCl in the buffer and the pipette solution containing (mmol/L) CsCl 100, NaCl 10, TEA-Cl 20, HEPES 10, Mg-ATP 5, and EGTA 5; pH 7.2 adjusted with CsOH. I Ca was elicited by 300-ms pulses from a holding potential of Ϫ40 to 0 mV at 0.1 Hz at 23°C.
Protein Phosphorylation Assays
Heart tissue was homogenized in 10 volumes buffer containing (mmol/L) histidine HCl 5 (pH 7.4), EDTA 10, Na 4 4 , 0.5 mmol/L ATP, and 15% trichloroacetic acid. After centrifugation (2000g, 20 minutes), the precipitate was directly processed for electrophoresis. The gels were exposed to x-ray films, and the respective bands for TnI and C protein were cut out to quantify the 32 P incorporation. The backphosphorylation data are expressed as pmol phosphate incorporation/mg protein.
Site-Specific PLB Phosphorylation
After homogenization, proteins were solubilized in sample buffer (50 mmol/L H 3 PO 4 , 5 mmol/L EDTA, 2% SDS, 1% mercaptoethanol, and 10% glycerol, pH 6.8 adjusted with Tris). Under these conditions, PLB is fully dissociated into its monomeric form. Proteins were resolved by 7.5% urea/SDS-PAGE and transferred to polyvinylidene difluoride membranes (Serva). Membranes were incubated with 5% dried milk in TBST (50 mmol/L Tris, 150 mmol/L NaCl, 0.1% and then with the phosphorylation site-specific PLB antibodies (PS-16 or PT-17, 1:10 000, PhosphoProtein Research). The immunoreaction was detected by chemiluminescence (Amersham).
PLB phosphorylation was also examined in canine ventricular myocytes incubated for 10 minutes with NE (10 nmol/L to 1 mol/L) or Zin (0.1 to 10 mol/L); 15% SDS was added, and samples were processed as described above. In some experiments, cells were pretreated for 5 minutes with ICI (100 nmol/L) or CGP (300 nmol/L).
Other Assays
cAMP levels were analyzed in trichloroacetic acid extracts, purified by column chromatography. 17 PKA activity of the soluble and particulate fractions was analyzed by a modified method of Murray et al. 18 Homogenates were centrifuged at 6000g for 5 minutes: the resulting supernatant was taken to represent the soluble PKA activity, and the resuspended pellet, the particulate fraction. PKA activity is expressed as the activity ratio of malantide phosphorylation in the absence and presence of cAMP 2.8 mol/L. The conversion of phosphorylase b to phosphorylase a (expressed as percentage of total activity) was measured according to England. 19 Protein concentration was determined by the method of Lowry et al, 20 using ovalbumin as standard.
Statistics
Results are presented as meanϮSEM. Statistical significance was determined by unpaired or paired t test or ANOVA when appropriate. Values of PϽ0.05 were considered to be statistically significant.
Results

␤-AR Signaling in the Intact Dog
Both ␤ 1 -AR and ␤ 2 -AR Stimulation Enhance Cardiac Function Representative tracings of the effects of NE and Zin are illustrated in Figure 1 . The cardiac responses (HR, LVP, and ϮdP/dt) reached a maximal level at 20 to 30 seconds after the drug bolus. The average values of HR, LVP, ϩdP/dt, ϩdP/dt/P, and t 1/2 under control conditions and after varying drug regimens are listed in the Table. Figure 2A shows the responses to ␤-AR stimulation in intact dog. After injection of the ␤ 1 -AR agonist, NE, HR, and ϩdP/dt/P were markedly increased, whereas t 1/2 was significantly reduced, consistent with previous studies. The effects of NE were completely prevented by the ␤ 1 -AR antagonist Bis (0.6 mg/kg body wt) ( Figure 2A and Table) , indicating that in intact dog, similar to rat ventricular myocytes, the NE-induced cardiac response is mediated by ␤ 1 -AR stimulation. 1 It is noteworthy that HR and ϩdP/dt/P were reduced 32% and t 1/2 increased 23% by pretreatment with Bis (Table) , whereas ICI had no additional effect, suggesting that under basal conditions, only ␤ 1 -AR stimulation is tonically involved in the cardiac regulation. The increase in t 1/2 over the control level after Bis (Table) represents, at least in part, the background ␤ 1 -AR activation under these experimental conditions.
To measure specific ␤ 2 -AR-mediated effects, Bis (0.6 mg/kg body wt) was infused before the ␤ 2 -AR agonist Zin (50 g/kg body wt). In the presence of Bis, Zin still significantly increased both HR and contractility and decreased t 1/2 (Table, Figures 1B and 2B ). Although the relative augmentations of HR and ϩdP/dt/P induced by ␤ 2 -AR stimulation were comparable to those of ␤ 1 -AR stimulation, the ␤ 2 -AR-induced decrease in t 1/2 was relatively smaller (Figure 2 ). The ␤ 2 -ARmediated responses were specifically abolished by the ␤ 2 -AR antagonist ICI ( Figure 2B and Table) , further confirming that the effects of Zin in the presence of Bis are mediated by ␤ 2 -AR. It is noteworthy that although ␤ 2 -AR stimulation significantly increased ϩdP/dt, it had no significant effect on LVP. The difference between the effects of Zin and NE on LVP is probably attributable to an additional vasodilatory effect of ␤ 2 -AR stimulation.
cAMP Accumulation Induced by ␤ 2 -AR Stimulation
In the freeze-clamped heart tissue of the same dogs as used for the functional studies, both ␤ 1 -AR stimulation by NE and ␤ 2 -AR stimulation by Zin in the presence of the ␤ 1 -AR antagonist Bis markedly increased total cellular cAMP to a similar extent (Figure 3 ). The NE-and Zin-induced augmentations in cAMP were completely blocked by Bis or ICI, respectively ( Figure 3 ).
␤ 2 -AR Stimulation Fails to Increase PKA Activity Next, we characterized the effects of ␤-AR subtype stimulation on PKA activation. Both the soluble and the particulate fractions were examined, because previous studies have suggested that the particulate fraction contains the functional component mediating protein phosphorylation. 21 NE significantly increased PKA activity by 60% to 70% in both fractions (Figure 4) , and this was inhibited in the particulate fraction by Bis. This biochemical result is in good agreement with the functional results described above ( Figures 1 and 2 and Table) . In sharp contrast, PKA activity was not elevated by Zin plus Bis in either the soluble or the particulate fraction, despite the significant increases in HR, contractility, and accelerated relaxation as well as the enhanced cAMP levels. To further investigate this difference in ␤-AR subtype signaling, we measured the cAMP-dependent phosphorylation of several PKA target proteins.
PLB Phosphorylation
PLB plays an important role in modulating SR Ca 2ϩ pump activity, [22] [23] [24] and its phosphorylation at Ser16 and Thr17 is mediated by PKA and Ca 2ϩ /calmodulin-dependent kinase II, respectively. 25, 26 Phosphorylation site-specific PLB antibodies 27 were used in the present study to determine whether ␤-AR subtype stimulation differentially regulates PLB phosphorylation. In the absence of ␤-AR stimulation, only a minor PLB phosphorylation is detectable. ␤ 1 -AR but not ␤ 2 -AR stimulation increased the PKA-catalyzed PLB phosphorylation at Ser16 ( Figure 5 ). The NE-induced PLB phosphorylation was blocked by the ␤ 1 -AR antagonist ( Figure 5 ). The lack of PLB phosphorylation after ␤ 2 -AR stimulation is consistent with the lack of PKA activation by Zin (Figure 4 ) and in agreement with previous studies that detected different PLB mobility forms. 13 However, previous studies did not distinguish the phosphorylation sites. To test whether a ␤ 2 -AR-stimulated increase in [Ca 2ϩ ] i enhances Thr17 phosphorylation of PLB via Ca 2ϩ /calmodulin-dependent kinase II, resulting in the positive lusitropic effect, we also examined the effects of ␤-AR subtype stimulation on phosphorylation of Thr17 PLB. The ␤ 2 -AR agonist Zin did not increase the phosphorylation of PLB at Thr17 either ( Figure 5 ), even though ␤ 1 -AR stimulation by NE markedly enhanced the Thr17 phosphorylation. This result provides the first evidence that ␤ 2 -AR stimulation produces a positive lusitropic effect in vivo, as manifested by a decrease in t 1/2 , without increasing PLB phosphorylation at either Ser16 or Thr17.
Phosphorylation of Myofilament Proteins
The ␤-AR-induced, cAMP-dependent phosphorylation of the myofilament protein TnI was assessed with the backphosphorylation technique ( Figure 6 ). In this assay, 32 P incorporation is used to indicate the in vivo protein phosphorylation status, ie, a lesser 32 P incorporation indicates a greater agonist-induced phosphorylation. A 42.6Ϯ4.0% reduction in 32 P incorporation was detected in animals exposed to NE, indicating a significant increase in the in vivo phosphorylation state. However, ␤ 2 -AR stimulation did not alter the amount of 32 P incorporation and therefore had no effect on TnI phosphorylation.
In addition, the phosphorylation of another myofilament component, C protein, was studied with the same method ( Figure 6 ). A 62.9Ϯ1.3% decrease in 32 P incorporation, detected only in NE-treated animals, indicates an increased phosphorylation state of this protein in vivo in response to ␤ 1 -AR stimulation. This phosphorylation was also entirely abolished by Bis. Thus, ␤ 1 -AR but not ␤ 2 -AR stimulation induced PKA-catalyzed phosphorylation of the myofilament proteins TnI and C protein.
Conversion of Phosphorylase b to Phosphorylase a
In addition to modulation of HR and contractility, ␤-AR stimulation is also critically involved in the regulation of cardiac energy metabolism. For example, glycogen phosphorylase, an important enzyme involved in glycogen synthesis and breakdown, is activated by phosphorylase kinase-dependent phosphorylation, which can be activated by PKAdependent phosphorylation. We demonstrated, for the first time, that glycogen phosphorylase did not respond to ␤ 2 -AR stimulation, whereas NE induced a marked augmentation in the conversion of phosphorylase b to phosphorylase a ( Figure  7 ). This result suggests that ␤ 1 -AR but not ␤ 2 -AR stimulation is linked to energy metabolism in association with the increased cardiac performance. Thus, the results from Figures 5 through 7 indicate that none of the nonsarcolemmal PKA target proteins examined are accessible to the ␤ 2 -AR signaling pathway. However, it is noteworthy that the sarcolemmal L-type Ca 2ϩ channel phosphorylation cannot be determined by any presently available techniques.
␤-AR Signaling in Single Canine Cardiomyocytes
To verify the results obtained in the intact dog and to measure I Ca , we performed additional studies in isolated canine myocytes. Consistent with the results from the intact dog, both ␤ 1 -AR stimulation by NE 0.1 mol/L and ␤ 2 -AR stimulation by Zin 1.0 mol/L produced positive inotropic effects, which were totally abolished by the ␤-AR antagonists CGP 300 nmol/L and ICI 100 nmol/L, respectively ( Figure 8A ). The average dose-response curves of contraction and t 1/2 to ␤-AR subtype stimulation are shown in Figure 9 . Both NE and Zin significantly increased contraction amplitude and abbreviated t 1/2 of contraction in a dose-dependent manner with a higher sensitivity to ␤ 1 -AR stimulation (Figure 9 ). The small decrease in contractility at the highest NE dose is probably due to the occurrence of spontaneous oscillations. In contrast to the observation in the intact dog, ␤ 2 -AR stimulation had no significant effect on cAMP accumulation ( Figure 10A ), which is consistent with previous studies in isolated canine myocytes. 13 In the intact dog, the ␤ 2 -AR agonist Zin at any concentration tested failed to induce PLB phosphorylation at either Ser16 ( Figure 10B ) or Thr17 (data not shown). The above in vivo and in vitro results indicate that in contrast to ␤ 1 -AR activation, ␤ 2 -AR-stimulated contractile and relaxant effects are not accompanied by an increase in cAMP or cAMP-dependent phosphorylation of myofilament or SR proteins. The critical question, then, is how ␤ 2 -AR stimulation increases contractility and accelerates cardiac relaxation without phosphorylation of PLB and myofilament proteins. The ␤ 2 -AR-mediated contractile effects are mediated by an augmentation of I Ca , as shown by a typical example in Figure  11A and the average data in Figure 11B . To determine whether the ␤ 2 -AR-induced augmentation of I Ca , in the absence of phosphorylation of PLB and other proteins remote from the sarcolemma, is mediated by a localized cAMP signaling, we examined effects of PKA inhibitors on ␤ 2 -AR-mediated contractile and I Ca responses. The PKA inhibitor H-89 2 mol/L 28 completely reversed the positive inotropic ( Figure 8B ) and relaxant (not shown) effects induced by ␤ 1 -AR and ␤ 2 -AR stimulation, whereas H-89 alone had no significant effect on basal contraction and did not block the positive inotropic effect of high extracellular Ca 2ϩ (4.0 mmol/L) (data not shown). Furthermore, the involvement of cAMP/PKA in the ␤ 2 -AR-mediated I Ca response was separately investigated by dialysis of an inhibitory cAMP analogue, Rp-cAMPS (100 mol/L). As shown in Figure 11 , the ␤ 2 -AR agonist Zin-induced increase in I Ca was totally abolished by Rp-cAMPS, whereas it had no significant effect on the basal I Ca . These results indicate that even though there are no detectable increases in PKA activation and PKA-dependent phosphorylation of cytoplasmic proteins, ␤ 2 -AR-stimulated augmentation of I Ca and the contractile and relaxant effects in the canine heart do require cAMPdependent PKA activation, which is apparently localized within or near the sarcolemma, and cannot be measured by presently available techniques.
Discussion
To determine the functional importance of ␤ 2 -AR stimulation in vivo, we compared ␤ 1 -AR-and ␤ 2 -AR-mediated HR contractile and relaxant responses in anesthetized, reserpinized intact dogs. ␤ 2 -AR was selectively stimulated by Zin in combination with a ␤ 1 -AR antagonist to inhibit potential tonic background or any reflex ␤ 1 -AR stimulation. The results demonstrate, for the first time, that in an intact animal model, ␤ 2 -AR stimulation produces a significant increase in HR and inotropic and lusitropic responses.
A similar increase in cellular cAMP after ␤ 2 -AR or ␤ 1 -AR subtype stimulation was observed in the intact dog, consistent with the ␤-AR-mediated increase in adenylate cyclase activity in dog LV biopsies. 29 In contrast, the present and previous studies in single canine ventricular myocytes 13 have demonstrated that Zin had no effect on total cAMP accumulation over a wide dose range, even though mixed ␤-AR stimulation or specific ␤ 1 -AR stimulation ( Figure 10 ) still markedly increases cAMP levels in these myocytes. 13 This difference in cAMP accumulation between isolated cardiomyocytes and heart tissue might be due to a ␤ 2 -AR-stimulated cAMP production in other cell types, such as vascular smooth muscle cells or endothelial cells, in which higher levels of ␤ 2 -AR are present. 30 Previous studies have shown that in rat and canine ventricular myocytes, ␤ 2 -AR stimulation induces a contractile effect and an increase in I Ca without enhancing PLB phosphorylation. 12, 13 Here, we systematically examined the phosphorylation of major regulatory proteins involved in cardiac excitation-contraction coupling as well as in energy metabolism. Specifically, we examined PKA target proteins located within different subcellular compartments to determine whether there is a uniform pattern or alternatively, a substrate-dependent phosphorylation after ␤-AR subtype stimulation. The present results illustrate that ␤ 2 -AR stimulation failed to elicit a detectable PKA activation, conversion of phosphorylase b to a in the cytoplasm, or PKA-dependent phosphorylation of PLB in the SR and myofilament proteins. In contrast, the ␤ 1 -AR-stimulated cardiac effects are well correlated with an increase in PKA activity and phosphorylation of these key regulatory proteins. These observations, together with the results of recent studies, 13 clearly show that the ␤ 1 -AR and the ␤ 2 -AR signaling pathways are not identical in nature. Indeed, it has already been proposed that the ␤ 2 -AR-mediated cardiac effects might be cAMPindependent, mediated through a direct interaction between G s and voltage-sensitive Ca 2ϩ channels 5, 6 or an increase in myofilament sensitivity to cytosolic Ca 2ϩ via increasing intracellular pH. 31 However, PKA inhibition completely abolished the contractile and I Ca responses to ␤ 2 -AR as well as ␤ 1 -AR stimulation in single canine myocytes, indicating that ␤ 2 -AR stimulation still requires cAMP/PKA signaling to augment I Ca and to produce its positive inotropic and relaxant effects. Because ␤ 2 -AR-directed cAMP signaling modulates I Ca without influencing the phosphorylation of the regulatory proteins examined, including its nearest neighbor, PLB, and because there is no detectable elevation of PKA activation in the intact dog after ␤ 2 -AR stimulation, we propose that the ␤ 2 -AR-activated cAMP/PKA signaling may be highly localized to a subsarcolemmal microdomain, in the vicinity of L-type Ca 2ϩ channels, but is excluded from the bulk cytoplasm. The observation of localized ␤ 2 -AR cAMP/PKA signaling in rat 14 and canine myocytes is in general agreement with the previous notion in frog cardiomyocytes that cAMP generated by local stimulation of ␤-ARs or direct activation of adenylate cyclase has different abilities to modulate remote L-type Ca 2ϩ channels. 32 The local regulation of L-type Ca 2ϩ channels is supported by the close spatial association of the channels with adenylate cyclase and PKA. 33, 34 The specific mechanisms mediating the local control of ␤ 2 -AR-stimulated cAMP/PKA signaling in canine hearts cannot be determined from the present results. Our previous studies in rat and mouse ventricular myocytes have shown that ␤ 2 -AR dually couples to G s and G i and that inhibition of ␤ 2 -AR coupling to G i enhances the ␤ 2 -AR-induced contractile and relaxation effects in these cells. 10, 35 More importantly, in rat myocytes, an inhibition of G i function by pertussis toxin rescues the ␤ 2 -AR-mediated Ser16 PLB phosphorylation, 36 suggesting that the coupling of ␤ 2 -AR to G i might explain the localized nature of the ␤ 2 -AR-stimulated cAMP signaling.
It is widely accepted that ␤-adrenergic relaxant effects are closely associated with an increase in PLB phosphorylation, causing an increase in SR Ca 2ϩ pump activity through a removal of its inhibitory effect on the pump. [22] [23] [24] In addition, an augmentation in TnI phosphorylation after ␤-AR subtype stimulation might contribute to the relaxant effect. 37 Another novel finding of the present study is that the Zin-induced acceleration of relaxation occurs both in vivo and in vitro without any increase in TnI or PLB phosphorylation at either Ser16 or Thr17. Thus, our data indicate that neither PLB nor TnI phosphorylation is involved in the ␤ 2 -AR-induced relax-ant effect in canine hearts. Further studies are required to identify mechanisms underlying the ␤ 2 -AR-stimulated cardiac relaxation in dog.
In conclusion, we have shown that stimulation of both ␤-AR subtypes enhances canine cardiac function in vivo and in vitro via cAMP/PKA-dependent signaling. However, the ␤ 2 -AR-coupled cAMP/PKA signaling pathway differs from that of ␤ 1 -AR because it apparently affects only sarcolemmal L-type Ca 2ϩ channels and not SR, myofilament, and cytosolic proteins. Taken together, these results suggest that the ␤ 2 -AR-activated cAMP/PKA signaling might be localized to a subsarcolemmal microdomain.
